Doctors welcome new treatment for rare bone cancer

The Irish doctors who led the clinical trials for the development of a drug to treat a rare bone cancer have welcomed the announcement that treatment will be available for the first time.

Myelofibrosis, or MF as it is known, is a bone marrow disorder, which severely debilitates patients with the disease and can now be treated with a new drug called ruxolitinib.